Veracyte | VCYT - Selling And Administration Expenses


Veracyte reported $51.73M in Selling and Administration Expenses for its fiscal quarter ending in September of 2025.





Selling And Administration Expenses Change Date
Agilent USD 428M 37M Sep/2025
Arrowhead Research USD 37.18M 6.23M Sep/2025
Bruker USD 242.5M 11.1M Sep/2025
Exact Sciences USD 491.64M 35.94M Sep/2025
Illumina USD 256M 59M Sep/2025
Laboratory Of America USD 552.4M 26.9M Sep/2025
Ligand Pharmaceuticals USD 28.45M 8.27M Sep/2025
Myriad Genetics USD 129M 1.3M Sep/2025
Roche Holding CHF 7.28B 3.99B Dec/2025
Siemens EUR 4.1B 526M Sep/2025
Sonic Healthcare AUD 2.52B 2.46B Dec/2024
Thermo Fisher Scientific USD 1.98B 182M Dec/2025
Veracyte USD 51.73M 5.91M Sep/2025
Waters USD 214.23M 12.97M Sep/2025